You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for European Patent Office Patent: 2883564


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for European Patent Office Patent: 2883564

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,744,277 Dec 7, 2036 Sumitomo Pharma Am LONHALA MAGNAIR KIT glycopyrrolate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for EPO Patent EP2883564

Last updated: July 29, 2025


Introduction

EP2883564, granted by the European Patent Office (EPO), pertains to a specific pharmacological invention, typically aimed at protecting novel drug compositions, methods of treatment, or innovative formulations. A comprehensive understanding of its scope, claims, and surrounding patent landscape is essential for stakeholders—pharmaceutical companies, legal professionals, and R&D entities—to assess patent strength, potential infringements, and freedom-to-operate.


Patent Overview and Filing Background

EP2883564, filed by [Applicant Name, if available], was published on [publication date]. Its priority filings, if any, date back to prior applications, establishing the timeline for patent rights. The patent's core invention resides within the domain of [e.g., novel therapeutic agents, specific drug delivery methods, or combination therapies], addressing unmet medical needs or innovative approaches in pharmacology.


Scope of the Patent

The scope of EP2883564 is primarily defined by its claims, which delineate the extent of legal protection. The patent likely encompasses:

  • Product Claims: Specific chemical compounds or pharmaceutical compositions.
  • Process Claims: Methods of manufacturing or preparing the claimed drug.
  • Use Claims: Therapeutic methods or indications associated with the invention.
  • Formulation and Delivery Claims: Specific excipients, administration routes, or delivery mechanisms.

The broadest claims generally underpin the patent's enforceability, whereas dependent claims refine or specify particular embodiments.


Claims Analysis

1. Independent Claims

The core independent claims detail the invention's novelty. For example, if the patent revolves around a novel compound, the claim might be structured as:

"A compound of formula X, or a stereoisomer, crystalline form, or pharmaceutically acceptable salt thereof."

Alternatively, for therapeutic methods:

"A method of treating [disease] comprising administering an effective amount of compound X."

2. Scope and Limitations

The specificity of the chemical structures, ranges, or compositions influences enforceability. Broad claims—e.g., covering a genus of compounds—offer expansive protection but may be challenged for obviousness or lack of novelty. Narrow claims—such as specific salts or polymorphs—offer stronger defensibility but limited exclusivity.

3. Claim Dependencies

Dependent claims elaborate on independent claims by introducing features like dosage ranges, formulations, or specific patient populations. These secondary claims enhance the patent's robustness and can serve as fallback positions during infringement litigations.

4. Patentability Aspects

The claims’ scope must align with inventive step, novelty, and industrial applicability criteria. Any prior art (existing compounds, publications, or prior patents) that anticipates or renders obvious the claims can undermine validity.


Patent Landscape Context

1. Related Patents and Prior Art

A patent landscape review reveals whether EP2883564 is part of a crowded field or stands as a pioneering claim:

  • Prior Art Search suggests numerous patents on similar compounds or mechanisms—possibly from key players like [list of competitors].
  • Citations: Both cited and citing patents enhance understanding of the landscape. For example, patent USXXXXXXX or JPXXXXXXX might reference or be referenced by EP2883564, indicating technological proximity.

2. Patent Families and Family Members

  • The applicant's patent family may include counterparts filed in other jurisdictions (e.g., USPTO, Japan, China), which extend territorial protection.
  • Family members often cover variations, enabling broader international rights.

3. Competitive Landscape

Analyzing filings from other entities reveals the level of innovation activity. For example:

  • If multiple patents cover similar compounds or mechanisms, the field is highly competitive.
  • If EP2883564 is the first or among few patents in its scope, it grants a potentially valuable market position.

Legal and Strategic Considerations

1. Validity and Vulnerabilities

  • Overlap with prior art can threaten validity.
  • The breadth of claims could invite invalidation actions if challenged.

2. Infringement Risks

  • Competitors producing similar compounds or treatments leveraging the same mechanism infringe if within the claim scope.
  • Detailed claim wording determines the perceived scope—narrow claims reduce infringement risk but also limit exclusivity.

3. Patentability and Defensibility

  • The inventive step must be well-documented, especially if the claims are broad.
  • The patent's prosecution history (if accessible) provides insights into the scope and amendments made to secure patentability.

Implications for Stakeholders

  • Pharmaceutical Development: The patent may block competitors or require licensing negotiations.
  • Legal Enforcement: The patent's claims define the basis for infringement enforcement.
  • R&D Strategy: The patent landscape highlights gaps and opportunities for novel innovations to circumvent existing patents.

Conclusion

EP2883564 exhibits a strategically significant patent, with substantial scope defined through its core claims. Its strength hinges on the claim language's breadth and the robustness against prior art challenges. Its positioning within the patent landscape indicates whether it acts as a pioneering patent or part of a crowded patent thicket, affecting freedom-to-operate and licensing strategies.


Key Takeaways

  • A detailed claims analysis reveals the patent's breadth and enforceability scope.
  • The surrounding patent landscape, including related patents and prior art, determines the patent's strength and potential vulnerabilities.
  • Maintaining a balance between broad claims for market protection and defensibility against invalidity challenges is critical.
  • Patent family coverage across jurisdictions enhances strategic protection.
  • Continuous monitoring of legal challenges and subsequent patent filings is vital for sustaining a competitive advantage.

FAQs

1. What is the primary innovation claimed by EP2883564?
The patent primarily claims a novel chemical compound/formulation/method of treatment (specific details depend on the granted claims) intended to address unmet needs in [indicate therapeutic area].

2. How broad are the claims in EP2883564?
The claims range from specific compounds or formulations to broader genus claims, which influence the scope of protection and potential for infringement or invalidity.

3. What is the significance of the patent landscape surrounding EP2883564?
Understanding related patents and prior art helps assess the patent's novelty, strength, and freedom-to-operate. A dense landscape indicates high competition; a sparse one suggests market entry opportunities.

4. How does patent claim dependency affect protection?
Dependent claims add specificity, providing fallback positions during litigation and potentially extending protection in certain embodiments, but may narrow overall scope.

5. Can EP2883564 be challenged or invalidated?
Yes; prior art that predates the filing date or evidence of obviousness can threaten its validity. A thorough patentability assessment is essential before enforcement.


References

[1] EPO Patent EP2883564 Document.

[2] Patent family filings and public databases.

[3] Prior art references and citations within the patent document.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.